Risk factors for sulfamethoxazole/trimethoprim‐induced severe cutaneous adverse reactions.

Bibliographic Details
Title: Risk factors for sulfamethoxazole/trimethoprim‐induced severe cutaneous adverse reactions.
Authors: Pinyopornpanish, Kanokkarn1,2 (AUTHOR), Chungcharoenpanich, Apinya1 (AUTHOR), Teepapan, Putthapon1 (AUTHOR), Thadanipon, Kunlawat3,4 (AUTHOR), Ruangwattanachok, Chulapha5 (AUTHOR), Lamrahong, Pansa5 (AUTHOR), Thongdee, Nattakirana1 (AUTHOR), Dechapaphapitak, Nizchapa1 (AUTHOR), Sukasem, Chonlaphat6,7,8,9,10,11 (AUTHOR), Pongphaew, Chanamon12 (AUTHOR), Jantararoungtong, Thawinee6,7 (AUTHOR), Koomdee, Napatrupron6,7 (AUTHOR), Laisuan, Wannada1 (AUTHOR) wannada.lai@mahidol.ac.th
Source: Clinical & Experimental Allergy. May2024, Vol. 54 Issue 5, p366-368. 3p.
Subject Terms: *STEVENS-Johnson Syndrome, *T cell receptors, *HLA histocompatibility antigens
Abstract: This article discusses the risk factors for sulfamethoxazole/trimethoprim (SMX/TMP)-induced severe cutaneous adverse reactions (SCARs). The study found that the HLA-B*13:01 allele is significantly associated with SMX/TMP-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Additionally, a higher daily dose of SMX/TMP was identified as a risk factor for SMX/TMP-induced SCARs. The study suggests that HLA-B*13:01 could be used as a predictive marker for identifying individuals at risk of developing DRESS after SMX/TMP treatment. However, further research is needed to validate these findings and determine the clinical utility of HLA gene testing in predicting adverse reactions to SMX/TMP. [Extracted from the article]
Copyright of Clinical & Experimental Allergy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:09547894
DOI:10.1111/cea.14470
Published in:Clinical & Experimental Allergy
Language:English